New study results imply that a 50-year-old man who learns that his "cardiovascular age" is 55 years may be more motivated to continue using his lipid-lowering drugs. Medscape Medical News
A cohort study showing an increased rate of hip bone loss suggests that the potential for bone loss should be considered when loop diuretics are prescribed to older patients in clinical practice. Medscape Medical News
Results of a randomized trial show that antihypertensive treatment with a sustained-release formulation of a diuretic reduces fatal stroke, all-cause mortality, and heart failure in elderly patients. Medscape Medical News
Six-week treatment with sibutramine appears to be efficacious, tolerable and safe in high-risk patients with CVD -- a population for whom sibutramine is usually contraindicated. European Heart Journal
Authors of a meta-analysis set out to see if diets, drugs, or surgery for weight loss in people with hypertension could produce meaningful reductions in hard cardiovascular events. Medscape Medical News
Three-year results from the SAPPHIRE trial comparing carotid stenting with distal protection and endarterectomy in patients at high surgical risk show no significant difference in major cardiovascular events between groups, researchers report. Medscape Medical News
